speb/financial-data huggingface dataset:
Financial ratios for BAND — quarterly report dated 2025-12-31
Total revenue: 207668000
Gross profit: 78077000
Operating income: -3926000
Net income: -3000000
Capital expenditures: 5073000
Operating cash flow: 38614000
Depreciation & amortization: 14106000
Net tangible assets: -95541000
Owner earnings: 6033000
Buffett classification: The Gruesome
Stock price: 15.45
Shares outstanding: 30059279
Book value: 399973000
P/B ratio: 1.1611180268418118
Market cap (USD): 464415860.54999995
Debt to equity: 1.2004685316258847
Current ratio: 1.4218489358525837
Quick ratio: 1.4218489358525837
Interest coverage ratio: -7.931313131313131
COGS to revenue (%): 62.40297012539246
R&D to revenue (%): 17.878536895429242
SG&A to revenue (%): 21.609010536047922
Free cash flow (dilution-adjusted): 17195000
Buyback yield (%): 0
Retained earnings: -84326000
Receivables turnover: 2.2718550689757024
Capitalized R&D asset: 69720530
ROCI (R&D-adjusted, %): -0.07845522481657916
Rosenberg metric: 0.1296352399418323
FCF margin (%): 8.280043145790396
Revenue growth (%): 8.219599260011986
Rule of 40 score: 16.499642405802383
Financial ratios for BAND — annual report dated 2025-12-31
Total revenue: 753817000
Gross profit: 295051000
Operating income: -14369000
Net income: -12912000
Capital expenditures: 22261000
Operating cash flow: 89491000
Depreciation & amortization: 53764000
Net tangible assets: -95541000
Owner earnings: 18591000
Buffett classification: The Gruesome
Stock price: 15.45
Shares outstanding: 30059279
Book value: 399973000
P/B ratio: 1.1611180268418118
Market cap (USD): 464415860.54999995
Debt to equity: 1.2004685316258847
Current ratio: 1.4218489358525837
Quick ratio: 1.4218489358525837
Interest coverage ratio: -7.085305719921105
COGS to revenue (%): 60.85906791701434
R&D to revenue (%): 17.57946557320941
SG&A to revenue (%): 23.46763206454617
Free cash flow (dilution-adjusted): 4218000
Buyback yield (%): 0
Retained earnings: -84326000
Receivables turnover: 8.246638733603913
Capitalized R&D asset: 246379130
ROCI (R&D-adjusted, %): -0.025852902765232593
Rosenberg metric: 0.12723073162096318
FCF margin (%): 0.5595522520717893
Revenue growth (%): 0.7121032162215243
Rule of 40 score: 1.2716554682933134
Financial ratios for BSL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.441382038770935
Shares outstanding: 10292168
Market cap (USD): 14834946.095212977
Buyback yield (%): 0
Retained earnings: 4630713.437953317
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSL.NS — annual report dated 2023-03-31
Total revenue: 57205383.67844093
Gross profit: 21215249.695493303
Operating income: 5184689.40316687
Net income: 2059598.0511571255
Capital expenditures: 19514762.484774668
Operating cash flow: 2292095.006090134
Depreciation & amortization: 1360974.4214372716
Net tangible assets: 12346151.035322778
Owner earnings: -16094190.01218027
Return on net tangible assets (%): -130.35795501070916
Capex to operating income (%): 376.3921224066927
Buffett classification: The Gruesome
Stock price: 1.8266747868453108
P/E ratio: 9.128210126734993
Shares outstanding: 10292168
Book value: 12676090.133982949
P/B ratio: 1.4831421667770084
Market cap (USD): 18800443.787576128
Debt to equity: 3.321344047844398
Current ratio: 1.1411684650239509
Quick ratio: 0.44899420272868534
Effective tax rate (%): 25.039122243156374
Interest coverage ratio: 2.513970670745752
COGS to revenue (%): 62.91389318399288
SG&A to revenue (%): 8.808187776505452
Free cash flow (dilution-adjusted): -18055200.974421438
Buyback yield (%): 0
Retained earnings: 5885200.974421438
Inventory turnover: 1.5934387720104315
Receivables turnover: 4.815366727911021
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.744653306405676
FCF margin (%): -31.562066038945087
Rule of 40 score: -31.562066038945087
Financial ratios for BSL.NS — annual report dated 2024-03-31
Total revenue: 78746396.45041372
Gross profit: 24249250.509653434
Operating income: 5628804.412999161
Net income: 1347008.0345365151
Capital expenditures: 2441875.5246432424
Operating cash flow: -4733157.452932006
Depreciation & amortization: 2200743.4944237918
Net tangible assets: 13206331.694447776
Owner earnings: 1105876.0043170648
Return on net tangible assets (%): 8.373831809646267
Capex to operating income (%): 43.38177960143676
Buffett classification: The Good
Stock price: 1.9100287907869482
P/E ratio: 14.594075681501229
Shares outstanding: 10292168
Book value: 13512843.266578734
P/B ratio: 1.4547891077991717
Market cap (USD): 19658337.199616123
Debt to equity: 3.8800925778019137
Current ratio: 1.1140742440826497
Quick ratio: 0.5017798797569041
Effective tax rate (%): 24.776325306045912
Interest coverage ratio: 1.5554274239246058
COGS to revenue (%): 69.20589182144596
SG&A to revenue (%): 7.472929168579105
Free cash flow (dilution-adjusted): -7435675.740496462
Buyback yield (%): 0
Retained earnings: 6653279.769756566
Inventory turnover: 2.161751904399026
Receivables turnover: 4.573059553116589
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.117862588404506
FCF margin (%): -9.442560009941124
Revenue growth (%): 37.655569086045624
Rule of 40 score: 28.2130090761045
Financial ratios for BSL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 13579037.267080745
Buffett classification: The Gruesome
Stock price: 2.561753463927377
Shares outstanding: 10292168
Book value: 13868131.868131869
P/B ratio: 1.9011931294012263
Market cap (USD): 26365997.025322504
Debt to equity: 3.57128436574106
Current ratio: 1.124549796891083
Quick ratio: 0.5626449428871385
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSL.NS — quarterly report dated 2025-03-31
Total revenue: 18178746.785129763
Gross profit: 6664706.570025719
Operating income: 940495.6745382276
Net income: 33119.00865092354
Capital expenditures: 0
Depreciation & amortization: 513771.33504793077
Net tangible assets: 13672469.02034136
Owner earnings: 546890.3436988543
Return on net tangible assets (%): 3.9999384374922515
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.904306220095694
P/E ratio: 147.94705773993115
Shares outstanding: 10292168
Book value: 13942599.953238256
P/B ratio: 1.4057234379817205
Market cap (USD): 19599439.54066986
Debt to equity: 3.5322936318282796
Current ratio: 1.1004621418836331
Quick ratio: 0.4241102390639264
Effective tax rate (%): -34.96903287279657
Interest coverage ratio: 1.0204858248239994
COGS to revenue (%): 63.33792065645879
Buyback yield (%): 0
Retained earnings: 7256079.0273556225
Inventory turnover: 0.40955211740945063
Receivables turnover: 1.1860156308990553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9665591895854404
Rule of 40 score: 0
Financial ratios for BSL.NS — annual report dated 2025-03-31
Total revenue: 77982288.98760813
Gross profit: 27962076.221650686
Operating income: 4887736.731353752
Net income: 953670.7972878185
Capital expenditures: 1322515.7820902502
Operating cash flow: 6664367.547346271
Depreciation & amortization: 2079331.3069908812
Net tangible assets: 13672469.02034136
Owner earnings: 1710486.3221884493
Return on net tangible assets (%): 12.510442112859465
Capex to operating income (%): 27.05783586105617
Buffett classification: The Good
Stock price: 1.904306220095694
P/E ratio: 20.551577752416733
Shares outstanding: 10292168
Book value: 13942599.953238256
P/B ratio: 1.4057234379817205
Market cap (USD): 19599439.54066986
Debt to equity: 3.5322936318282796
Current ratio: 1.1004621418836331
Quick ratio: 0.4241102390639264
Effective tax rate (%): 23.868673765550195
Interest coverage ratio: 1.314245568593675
COGS to revenue (%): 64.14304249764452
SG&A to revenue (%): 8.220108970625603
Free cash flow (dilution-adjusted): 5212578.91045125
Buyback yield (%): 0
Retained earnings: 7256079.0273556225
Inventory turnover: 1.779209006469845
Receivables turnover: 5.087711202856182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.417147265234357
FCF margin (%): 6.684311243133119
Revenue growth (%): -0.9703395929828224
Rule of 40 score: 5.713971650150297
Financial ratios for BSL.NS — quarterly report dated 2025-06-30
Total revenue: 18488813.47999064
Gross profit: 6445986.4263983155
Operating income: 932447.9288556051
Net income: 54434.82330915048
Capital expenditures: 0
Depreciation & amortization: 498139.48045869416
Owner earnings: 552574.3037678447
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6732974490989938
P/E ratio: 79.09393938091144
Shares outstanding: 10292168
Market cap (USD): 17221858.460098293
Effective tax rate (%): 18.82742976792881
Interest coverage ratio: 1.0235835120936148
COGS to revenue (%): 65.1357485250504
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.7056549525983307
Rule of 40 score: 1.7056549525983307
Financial ratios for BSL.NS — quarterly report dated 2025-09-30
Total revenue: 20782581.736189403
Gross profit: 6605918.827508455
Operating income: 1076967.305524239
Net income: 193945.88500563698
Capital expenditures: 0
Depreciation & amortization: 468759.8647125141
Net tangible assets: 13323314.543404734
Owner earnings: 662705.749718151
Return on net tangible assets (%): 4.974030655503825
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.794250281848929
P/E ratio: 65.60122167755476
Shares outstanding: 10292168
Book value: 13568906.426155575
P/B ratio: 1.3609590010319375
Market cap (USD): 18466725.334836528
Debt to equity: 3.663937545386114
Current ratio: 1.0686719616324336
Quick ratio: 0.492331686292841
Effective tax rate (%): 16.47001699441612
Interest coverage ratio: 1.2704579005466081
COGS to revenue (%): 68.21415687731736
Buyback yield (%): 0
Inventory turnover: 0.5616082163344129
Receivables turnover: 1.0959016086449134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.516765813886453
Revenue growth (%): 12.406249101280485
Rule of 40 score: 12.406249101280485
Financial ratios for BSL.NS — quarterly report dated 2025-12-31
Total revenue: 18589929.82065278
Gross profit: 6475470.647209535
Operating income: 992001.7823326279
Net income: 131792.3582488582
Capital expenditures: 0
Depreciation & amortization: 469366.15795922914
Owner earnings: 601158.5162080873
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7270803163640414
P/E ratio: 43.009294955107464
Shares outstanding: 10292168
Market cap (USD): 17775400.765511863
Effective tax rate (%): 23.45862715921589
Interest coverage ratio: 1.2063724294887426
COGS to revenue (%): 65.16678271686908
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -10.550430852960321
Rule of 40 score: -10.550430852960321
Financial ratios for BSY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.36
Shares outstanding: 292281547
Market cap (USD): 13842454065.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSY — annual report dated 2022-12-31
Total revenue: 1099082000
Gross profit: 862069000
Operating income: 208612000
Net income: 174780000
Capital expenditures: 16166000
Operating cash flow: 274324000
Depreciation & amortization: 71537000
Net tangible assets: -1956705000
Owner earnings: 230151000
Return on net tangible assets (%): -11.76217160992587
Capex to operating income (%): 7.749314516902192
Buffett classification: The Great
Stock price: 36.34
P/E ratio: 60.77074847225084
Shares outstanding: 292281547
Book value: 573454000
P/B ratio: 18.521993774531175
Market cap (USD): 10621511417.980001
Debt to equity: 3.179048363077073
Current ratio: 0.6618758733078913
Quick ratio: 0.6618758733078913
Effective tax rate (%): 10.734081452528056
Interest coverage ratio: 5.950821542674578
COGS to revenue (%): 21.564633030110585
R&D to revenue (%): 23.4610338446085
SG&A to revenue (%): 32.25300750990372
Free cash flow (dilution-adjusted): 180572000
Buyback yield (%): 0.6760902208177169
Retained earnings: -370866000
Receivables turnover: 3.828580186921097
Capitalized R&D asset: 257856000
ROCI (R&D-adjusted, %): 13.616589425740463
FCF margin (%): 16.429347400830878
Rule of 40 score: 16.429347400830878
Financial ratios for BSY — annual report dated 2023-12-31
Total revenue: 1228413000
Gross profit: 962330000
Operating income: 230542000
Net income: 326787000
Capital expenditures: 25002000
Operating cash flow: 416696000
Depreciation & amortization: 71861000
Net tangible assets: -1634845000
Owner earnings: 373646000
Return on net tangible assets (%): -22.855133055427274
Capex to operating income (%): 10.844878590452064
Buffett classification: The Great
Stock price: 51.52
P/E ratio: 46.080001044839605
Shares outstanding: 292281547
Book value: 883982000
P/B ratio: 17.03467412395275
Market cap (USD): 15058345301.44
Debt to equity: 1.7768167225124494
Current ratio: 0.551785134205636
Quick ratio: 0.551785134205636
Effective tax rate (%): -78.0490064132253
Interest coverage ratio: 5.577943916188817
COGS to revenue (%): 21.660711829002135
R&D to revenue (%): 22.355592133915874
SG&A to revenue (%): 34.08088322087116
Free cash flow (dilution-adjusted): 318722000
Buyback yield (%): 0.39139094515493655
Retained earnings: -161932000
Receivables turnover: 4.184880219121334
Capitalized R&D asset: 447382520
ROCI (R&D-adjusted, %): 10.89735790508573
Rosenberg metric: 0.3888255460412013
FCF margin (%): 25.945834177918993
Revenue growth (%): 11.767183886188656
Rule of 40 score: 37.71301806410765
Financial ratios for BSY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.35
Shares outstanding: 292281547
Market cap (USD): 14716375891.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.34
Shares outstanding: 292281547
Market cap (USD): 13544326887.980001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSY — annual report dated 2024-12-31
Total revenue: 1353095000
Gross profit: 1095328000
Operating income: 302150000
Net income: 234787000
Capital expenditures: 14046000
Operating cash flow: 435292000
Depreciation & amortization: 64608000
Net tangible assets: -1540151000
Owner earnings: 285349000
Return on net tangible assets (%): -18.527339202454822
Capex to operating income (%): 4.648684428264107
Buffett classification: The Great
Stock price: 46.34
P/E ratio: 57.68772073402701
Shares outstanding: 292281547
Book value: 1041120000
P/B ratio: 13.009381135680806
Market cap (USD): 13544326887.980001
Debt to equity: 1.3702916090364223
Current ratio: 0.5428644757556482
Quick ratio: 0.5428644757556482
Effective tax rate (%): 20.039241780553137
Interest coverage ratio: 12.196254137402114
COGS to revenue (%): 19.050177555899623
R&D to revenue (%): 20.785458522867945
SG&A to revenue (%): 35.32146671150215
Free cash flow (dilution-adjusted): 346829000
Buyback yield (%): 0.5674922101017258
Retained earnings: -75941000
Receivables turnover: 4.302820327729141
Capitalized R&D asset: 550334210
ROCI (R&D-adjusted, %): 9.954576682452787
Rosenberg metric: 0.48430006663777814
FCF margin (%): 25.63227267856285
Revenue growth (%): 10.149843741477826
Rule of 40 score: 35.78211642004067
Financial ratios for BSY — quarterly report dated 2025-03-31
Total revenue: 370542000
Gross profit: 304883000
Operating income: 115184000
Net income: 91368000
Capital expenditures: 3044000
Operating cash flow: 219415000
Depreciation & amortization: 15640000
Net tangible assets: -1485723000
Owner earnings: 103964000
Return on net tangible assets (%): -6.997535879837629
Capex to operating income (%): 2.642728156688429
Buffett classification: The Great
Stock price: 39.1
P/E ratio: 31.269723775555995
Shares outstanding: 292281547
Book value: 1097689000
P/B ratio: 10.41115333004157
Market cap (USD): 11428208487.7
Debt to equity: 1.1680393991376428
Current ratio: 0.4923415015888749
Quick ratio: 0.4923415015888749
Effective tax rate (%): 18.321484462329533
Interest coverage ratio: 45.8170246618934
COGS to revenue (%): 17.719718682362593
R&D to revenue (%): 19.552439399582234
SG&A to revenue (%): 29.427433327396084
Free cash flow (dilution-adjusted): 198969000
Buyback yield (%): 0.34519846258019715
Retained earnings: -47681000
Receivables turnover: 1.220654895243115
Capitalized R&D asset: 72450000
ROCI (R&D-adjusted, %): 6.362738027638391
FCF margin (%): 53.696746927473804
Rule of 40 score: 53.696746927473804
Financial ratios for BSY — quarterly report dated 2025-06-30
Total revenue: 364106000
Gross profit: 295330000
Operating income: 84430000
Net income: 70500000
Capital expenditures: 4091000
Operating cash flow: 61085000
Depreciation & amortization: 15749000
Net tangible assets: -1447525000
Owner earnings: 82158000
Return on net tangible assets (%): -5.675756895390408
Capex to operating income (%): 4.845434087409688
Buffett classification: The Great
Stock price: 53.72
P/E ratio: 97.00104223713149
Shares outstanding: 292281547
Book value: 1162170000
P/B ratio: 13.51038548993693
Market cap (USD): 15701364704.84
Debt to equity: 1.103742998012339
Current ratio: 0.512046171554259
Quick ratio: 0.512046171554259
Effective tax rate (%): 11.190821408308643
Interest coverage ratio: 43.03261977573904
COGS to revenue (%): 18.88900485023592
R&D to revenue (%): 20.704135608861154
SG&A to revenue (%): 34.96619116411155
Free cash flow (dilution-adjusted): 37401000
Buyback yield (%): 0.22515240340288778
Retained earnings: -31374000
Receivables turnover: 1.250926756198702
Capitalized R&D asset: 123926500
ROCI (R&D-adjusted, %): 4.110932575238738
Rosenberg metric: -0.13185645272601795
FCF margin (%): 10.272008700762965
Revenue growth (%): -1.7369151135363872
Rule of 40 score: 8.535093587226578
Financial ratios for BSY — quarterly report dated 2025-09-30
Total revenue: 375549000
Gross profit: 303354000
Operating income: 84497000
Net income: 57373000
Capital expenditures: 5701000
Operating cash flow: 116376000
Depreciation & amortization: 18736000
Net tangible assets: -1396027000
Owner earnings: 70408000
Return on net tangible assets (%): -5.043455463253934
Capex to operating income (%): 6.746985100062725
Buffett classification: The Great
Stock price: 51.31
P/E ratio: 68.4040219510493
Shares outstanding: 292281547
Book value: 1195350000
P/B ratio: 12.546087904438032
Market cap (USD): 14996966176.570002
Debt to equity: 1.0735324381980174
Current ratio: 0.6122690901906549
Quick ratio: 0.6122690901906549
Effective tax rate (%): 31.366552379131974
Interest coverage ratio: 50.35578069129917
COGS to revenue (%): 19.22385627441426
R&D to revenue (%): 20.96956722025621
SG&A to revenue (%): 35.13735890656079
Free cash flow (dilution-adjusted): 92633000
Buyback yield (%): 0.12408509681826939
Retained earnings: -13870000
Receivables turnover: 1.3123466798990795
Capitalized R&D asset: 153167450
ROCI (R&D-adjusted, %): 3.1815099238542075
Rosenberg metric: 0.10644027326391192
FCF margin (%): 24.666022276720216
Revenue growth (%): 3.1427661175591726
Rule of 40 score: 27.80878839427939
Financial ratios for BSY — quarterly report dated 2025-12-31
Total revenue: 391582000
Gross profit: 320682000
Operating income: 78510000
Net income: 58667000
Capital expenditures: 5419000
Operating cash flow: 141588000
Depreciation & amortization: 15755000
Net tangible assets: -1485759000
Owner earnings: 69003000
Return on net tangible assets (%): -4.644292916953558
Capex to operating income (%): 6.9023054387976055
Buffett classification: The Great
Stock price: 38.1
P/E ratio: 40.07055191178375
Shares outstanding: 292281547
Book value: 1189492000
P/B ratio: 9.361918315297624
Market cap (USD): 11135926940.7
Debt to equity: 1.080066952951344
Current ratio: 0.5613699086658127
Quick ratio: 0.5613699086658127
Effective tax rate (%): 22.872466594628786
Interest coverage ratio: 8.563481675392671
COGS to revenue (%): 18.10604164644953
R&D to revenue (%): 20.682768870887834
SG&A to revenue (%): 39.06487019321624
Free cash flow (dilution-adjusted): 118630000
Buyback yield (%): 0.5732167635430578
Retained earnings: -40258000
Receivables turnover: 1.1426712188858736
Capitalized R&D asset: 158630220
ROCI (R&D-adjusted, %): 2.9461447989530787
Rosenberg metric: 0.22003530113903316
FCF margin (%): 30.295059527761747
Revenue growth (%): 4.269216533661386
Rule of 40 score: 34.564276061423136
Financial ratios for BSY — annual report dated 2025-12-31
Total revenue: 1501779000
Gross profit: 1224249000
Operating income: 362621000
Net income: 277861000
Capital expenditures: 18255000
Operating cash flow: 538464000
Depreciation & amortization: 65880000
Net tangible assets: -1485759000
Owner earnings: 325486000
Return on net tangible assets (%): -21.907052220447596
Capex to operating income (%): 5.03418169383461
Buffett classification: The Great
Stock price: 38.1
P/E ratio: 40.07732981850638
Shares outstanding: 292281547
Book value: 1189492000
P/B ratio: 9.361918315297624
Market cap (USD): 11135926940.7
Debt to equity: 1.080066952951344
Current ratio: 0.5613699086658127
Quick ratio: 0.5613699086658127
Effective tax rate (%): 20.806995634856143
Interest coverage ratio: 23.66668842187704
COGS to revenue (%): 18.480082622010297
R&D to revenue (%): 20.480776465778252
SG&A to revenue (%): 34.71109930289343
Free cash flow (dilution-adjusted): 447633000
Buyback yield (%): 1.4120423098799146
Retained earnings: -40258000
Receivables turnover: 4.382325133502582
Capitalized R&D asset: 586635760
ROCI (R&D-adjusted, %): 12.018602908814765
Rosenberg metric: 0.45839066727822875
FCF margin (%): 29.806849076994684
Revenue growth (%): 10.988437618940281
Rule of 40 score: 40.79528669593496
Financial ratios for BWO.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.7229190421892815
Shares outstanding: 181215735
Market cap (USD): 493435775.57582664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWO.OL — annual report dated 2022-12-31
Total revenue: 78350202.42914979
Gross profit: 57216599.190283395
Operating income: 13856275.303643724
Net income: 13127530.36437247
Capital expenditures: 71062753.03643724
Operating cash flow: 65819838.05668016
Depreciation & amortization: 21133603.238866396
Net tangible assets: 86082995.951417
Owner earnings: -36801619.43319838
Return on net tangible assets (%): -42.75132275132275
Capex to operating income (%): 512.8560993425858
Buffett classification: The Gruesome
Stock price: 2.33502024291498
P/E ratio: 32.233207451426374
Shares outstanding: 181215735
Book value: 116508097.1659919
P/B ratio: 3.631871259186865
Market cap (USD): 423142409.5597166
Debt to equity: 1.104769351055512
Current ratio: 0.8894254787676935
Quick ratio: 0.8782681099084096
Effective tax rate (%): 13.4936539746159
Interest coverage ratio: 2.8881856540084385
COGS to revenue (%): 26.973259268828322
SG&A to revenue (%): 2.506136158119106
Free cash flow (dilution-adjusted): -8289473.684210525
Buyback yield (%): 0
Inventory turnover: 31.16417910447761
Receivables turnover: 5.096115865701119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.723784548497291
FCF margin (%): -10.58002842010076
Rule of 40 score: -10.58002842010076
Financial ratios for BWO.OL — annual report dated 2023-12-31
Total revenue: 64754420.43222004
Gross profit: 46365422.39685658
Operating income: 11620825.14734774
Net income: 9862475.442043222
Capital expenditures: 59322200.39292731
Operating cash flow: 54882121.80746562
Depreciation & amortization: 18388998.035363458
Net tangible assets: 90157170.92337918
Owner earnings: -31070726.91552063
Return on net tangible assets (%): -34.46284593593376
Capex to operating income (%): 510.4818258664412
Buffett classification: The Gruesome
Stock price: 2.149312377210216
P/E ratio: 39.49203467928287
Shares outstanding: 181215735
Book value: 117416502.94695485
P/B ratio: 3.3171591080063574
Market cap (USD): 389489222.18074656
Debt to equity: 1.3112189408516688
Current ratio: 1.0478691173500305
Quick ratio: 1.0403958796202788
Effective tax rate (%): 13.85701676963813
Interest coverage ratio: 2.3898989898989895
COGS to revenue (%): 28.398058252427184
SG&A to revenue (%): 4.338592233009709
Free cash flow (dilution-adjusted): -24282907.662082516
Buyback yield (%): 0
Inventory turnover: 50.59459459459459
Receivables turnover: 7.072961373390558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.421052631578947
FCF margin (%): -37.5
Revenue growth (%): -17.352580561899746
Rule of 40 score: -54.85258056189974
Financial ratios for BWO.OL — annual report dated 2024-12-31
Total revenue: 53548102.38305384
Gross profit: 37846425.41924095
Operating income: 12365401.58870256
Net income: 10644307.149161518
Capital expenditures: 30891438.65842895
Operating cash flow: 32030008.82612533
Depreciation & amortization: 15701676.963812886
Net tangible assets: 89090909.0909091
Owner earnings: -4545454.545454543
Return on net tangible assets (%): -5.102040816326528
Capex to operating income (%): 249.82155603140615
Buffett classification: The Gruesome
Stock price: 2.602292768959436
P/E ratio: 44.3031556872461
Shares outstanding: 181215735
Book value: 110026478.37599292
P/B ratio: 4.28602645265673
Market cap (USD): 471576396.8121694
Debt to equity: 1.2819669501042836
Current ratio: 2.248709526044111
Quick ratio: 2.2313467855466915
Effective tax rate (%): 5.817610062893082
Interest coverage ratio: 3.638961038961039
COGS to revenue (%): 29.322564694247568
SG&A to revenue (%): 4.664578869292897
Free cash flow (dilution-adjusted): -1632833.1862312446
Buyback yield (%): 0
Inventory turnover: 48.08108108108108
Receivables turnover: 4.530993278566094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6557680766119565
FCF margin (%): -3.0492830064282184
Revenue growth (%): -17.305873443645623
Rule of 40 score: -20.355156450073842
Financial ratios for BWO.OL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 103286991.06256206
Buffett classification: The Gruesome
Stock price: 2.9791459781529293
Shares outstanding: 181215735
Book value: 127040714.99503475
P/B ratio: 4.249567771437505
Market cap (USD): 539868128.103277
Debt to equity: 1.2847651059172984
Current ratio: 2.387478108581436
Quick ratio: 2.387478108581436
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM.TO — annual report dated 2021-12-31
Capital expenditures: 6448818.897637795
Buffett classification: The Gruesome
Stock price: 0.31496062992125984
Shares outstanding: 213949766
Market cap (USD): 67385753.07086614
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -44117.647058823524
Operating income: -1652205.882352941
Net income: -1988970.588235294
Capital expenditures: 3298529.4117647056
Operating cash flow: -977941.1764705882
Depreciation & amortization: 44117.647058823524
Net tangible assets: 21700735.294117644
Owner earnings: -5243382.352941176
Return on net tangible assets (%): -24.162233591976417
Buffett classification: The Gruesome
Stock price: 0.13235294117647056
Shares outstanding: 213949766
Book value: 21700735.294117644
P/B ratio: 1.3048811669433809
Market cap (USD): 28316880.79411764
Debt to equity: 0.00870802697116525
Current ratio: 4.077894736842105
Quick ratio: 4.077894736842105
Interest coverage ratio: -31.64788732394366
Free cash flow (dilution-adjusted): -4475735.294117647
Buyback yield (%): 0
Retained earnings: -38806617.64705882
Receivables turnover: 0
Capitalized R&D asset: 15441.176470588234
ROCI (R&D-adjusted, %): -7.151550089674609
Rule of 40 score: 0
Financial ratios for CCM.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -67424.24242424242
Operating income: -1237121.2121212122
Net income: -2310606.0606060605
Capital expenditures: 3444696.9696969697
Operating cash flow: -1312878.7878787878
Depreciation & amortization: 67424.24242424242
Net tangible assets: 23286363.636363637
Owner earnings: -5687878.787878788
Return on net tangible assets (%): -24.425792179061748
Buffett classification: The Gruesome
Stock price: 0.1590909090909091
Shares outstanding: 213949766
Book value: 23286363.636363637
P/B ratio: 1.4616907690806167
Market cap (USD): 34037462.77272727
Debt to equity: 0.006994599518511288
Current ratio: 7.379551820728291
Quick ratio: 7.379551820728291
Interest coverage ratio: -42.973684210526315
Free cash flow (dilution-adjusted): -5053787.878787879
Buyback yield (%): 0
Retained earnings: -42057575.75757576
Receivables turnover: 0
Capitalized R&D asset: 10345.588235294117
ROCI (R&D-adjusted, %): -5.041540465010829
Rosenberg metric: -1.5093795093795093
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2024-09-30
Capital expenditures: 1948888.8888888888
Buffett classification: The Gruesome
Stock price: 0.24444444444444444
Shares outstanding: 213949766
Market cap (USD): 52298831.688888885
Buyback yield (%): 0.03540904819572262
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.19580419580419584
Shares outstanding: 213949766
Market cap (USD): 41892261.87412588
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -56643.356643356645
Operating income: -1018181.8181818182
Net income: -784615.3846153846
Capital expenditures: 3965034.9650349654
Operating cash flow: -254545.45454545456
Depreciation & amortization: 56643.356643356645
Net tangible assets: 20965034.965034965
Owner earnings: -4693006.993006993
Return on net tangible assets (%): -22.384923282188126
Buffett classification: The Gruesome
Stock price: 0.19580419580419584
Shares outstanding: 213949766
Book value: 20965034.965034965
P/B ratio: 1.9981966137424954
Market cap (USD): 41892261.87412588
Debt to equity: 0.005003335557038025
Current ratio: 1.1525252525252525
Quick ratio: 1.1525252525252525
Interest coverage ratio: -121.33333333333334
Free cash flow (dilution-adjusted): -4440559.44055944
Buyback yield (%): 0
Retained earnings: -39602797.202797204
Receivables turnover: 0
Capitalized R&D asset: 5095.588235294117
ROCI (R&D-adjusted, %): -4.60722588504362
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -13286.713286713288
Operating income: -239160.83916083918
Net income: -292307.6923076923
Capital expenditures: 626573.4265734266
Operating cash flow: -23776.22377622378
Depreciation & amortization: 13286.713286713288
Net tangible assets: 22207692.307692308
Owner earnings: -905594.4055944056
Return on net tangible assets (%): -4.077841105897912
Buffett classification: The Gruesome
Stock price: 0.2377622377622378
Shares outstanding: 213949766
Book value: 22207692.307692308
P/B ratio: 2.29061058790188
Market cap (USD): 50869175.132867135
Debt to equity: 0.004314009509714394
Current ratio: 2.052924791086351
Quick ratio: 2.052924791086351
Interest coverage ratio: -171.00000000000003
Free cash flow (dilution-adjusted): -723076.9230769231
Buyback yield (%): 0
Retained earnings: -39895104.8951049
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.017493752231346
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -13868.61313868613
Operating income: -310218.9781021898
Net income: -318248.1751824817
Capital expenditures: 0
Operating cash flow: -231386.8613138686
Depreciation & amortization: 13868.61313868613
Net tangible assets: 24135036.496350363
Owner earnings: -304379.5620437956
Return on net tangible assets (%): -1.2611522758203537
Buffett classification: The Gruesome
Stock price: 0.2773722627737226
Shares outstanding: 213949766
Book value: 24135036.496350363
P/B ratio: 2.4588208401633147
Market cap (USD): 59343730.71532846
Debt to equity: 0.0039618932405867235
Current ratio: 0.9396914446002805
Quick ratio: 0.9396914446002805
Interest coverage ratio: -141.66666666666666
Free cash flow (dilution-adjusted): -856204.3795620438
Buyback yield (%): 0.004919994065089879
Retained earnings: -41951094.89051095
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2117583326205343
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -13669.06474820144
Operating income: -456115.1079136691
Net income: -413669.06474820146
Capital expenditures: 1028776.9784172663
Operating cash flow: -184892.08633093527
Depreciation & amortization: 13669.06474820144
Net tangible assets: 24905035.971223023
Owner earnings: -1428776.9784172662
Return on net tangible assets (%): -5.736899878675833
Buffett classification: The Gruesome
Stock price: 0.3381294964028777
Shares outstanding: 213949766
Book value: 24905035.971223023
P/B ratio: 2.904742908891328
Market cap (USD): 72342726.63309352
Debt to equity: 0.003293084522502744
Current ratio: 2.187937062937063
Quick ratio: 2.187937062937063
Interest coverage ratio: -316.99999999999994
Free cash flow (dilution-adjusted): -1456834.5323741008
Buyback yield (%): 0
Retained earnings: -41762589.92805756
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7201150360844322
Rule of 40 score: 0
Financial ratios for CCM.TO — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -13868.61313868613
Operating income: -208759.12408759122
Net income: -848175.1824817518
Capital expenditures: 910218.9781021897
Operating cash flow: -151824.81751824816
Depreciation & amortization: 13868.61313868613
Net tangible assets: 24797810.2189781
Owner earnings: -1744525.5474452553
Return on net tangible assets (%): -7.034998381067319
Buffett classification: The Gruesome
Stock price: 0.3284671532846715
Shares outstanding: 213949766
Book value: 24797810.2189781
P/B ratio: 2.8339385600329674
Market cap (USD): 70275470.58394161
Debt to equity: 0.0030023842463132487
Current ratio: 0.8133547868061142
Quick ratio: 0.8133547868061142
Interest coverage ratio: -143
Free cash flow (dilution-adjusted): -1030656.9343065693
Buyback yield (%): 0
Retained earnings: -43220437.95620438
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7692307692307693
Rule of 40 score: 0
Financial ratios for CCM.TO — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -55474.45255474452
Operating income: -1228467.1532846715
Net income: -1892700.729927007
Capital expenditures: 3121167.8832116784
Operating cash flow: -596350.3649635036
Depreciation & amortization: 55474.45255474452
Net tangible assets: 24797810.2189781
Owner earnings: -4958394.160583941
Return on net tangible assets (%): -19.995290377652843
Buffett classification: The Gruesome
Stock price: 0.3284671532846715
Shares outstanding: 213949766
Book value: 24797810.2189781
P/B ratio: 2.8339385600329674
Market cap (USD): 70275470.58394161
Debt to equity: 0.0030023842463132487
Current ratio: 0.8133547868061142
Quick ratio: 0.8133547868061142
Interest coverage ratio: -187.00000000000003
Free cash flow (dilution-adjusted): -4119708.02919708
Buyback yield (%): 0
Retained earnings: -43220437.95620438
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.5266272189349115
Rule of 40 score: 0
Financial ratios for CLH — annual report dated 2021-12-31
Capital expenditures: 219700000
Depreciation & amortization: 263400000
Buffett classification: The Gruesome
Stock price: 99.77
Shares outstanding: 52846032
Market cap (USD): 5272448612.639999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLH — annual report dated 2022-12-31
Total revenue: 5166605000
Gross profit: 1622675000
Operating income: 634747000
Net income: 411744000
Capital expenditures: 336277000
Operating cash flow: 626214000
Depreciation & amortization: 347594000
Net tangible assets: 54662000
Owner earnings: 423061000
Return on net tangible assets (%): 773.9581427682851
Capex to operating income (%): 52.978115690188375
Buffett classification: The Good
Stock price: 114.12
P/E ratio: 14.646938806248542
Shares outstanding: 52846032
Book value: 1922322000
P/B ratio: 3.1372419250468964
Market cap (USD): 6030789171.84
Debt to equity: 1.3492115264768338
Current ratio: 1.9936996002329197
Quick ratio: 1.6751073920638686
Effective tax rate (%): 23.467373484659795
Interest coverage ratio: 5.653754342210742
COGS to revenue (%): 68.59301223917834
SG&A to revenue (%): 12.143196547829763
Free cash flow (dilution-adjusted): 252348000
Buyback yield (%): 0.8321133200000277
Retained earnings: 1584722000
Inventory turnover: 10.904601315716597
Receivables turnover: 4.821334754244303
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.422604216796849
FCF margin (%): 4.884213134156763
Rule of 40 score: 4.884213134156763
Financial ratios for CLH — annual report dated 2023-12-31
Total revenue: 5409152000
Gross profit: 1663028000
Operating income: 612439000
Net income: 377856000
Capital expenditures: 412650000
Operating cash flow: 734552000
Depreciation & amortization: 365761000
Net tangible assets: 356973000
Owner earnings: 330967000
Return on net tangible assets (%): 92.71485518512604
Capex to operating income (%): 67.37813888403579
Buffett classification: The Good
Stock price: 174.51
P/E ratio: 24.40654917301829
Shares outstanding: 52846032
Book value: 2247506000
P/B ratio: 4.103286507052706
Market cap (USD): 9222161044.32
Debt to equity: 1.107845763259364
Current ratio: 1.977971869918856
Quick ratio: 1.6623098742502678
Effective tax rate (%): 24.92116698689991
Interest coverage ratio: 5.081427089815391
COGS to revenue (%): 69.25529177216687
SG&A to revenue (%): 12.407878351357107
Free cash flow (dilution-adjusted): 288900000
Buyback yield (%): 0.5547940418098891
Retained earnings: 1962578000
Inventory turnover: 11.438162382332196
Receivables turnover: 4.958112505385116
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.457454840971524
FCF margin (%): 5.340948082065359
Revenue growth (%): 4.694514095813402
Rule of 40 score: 10.035462177878761
Financial ratios for CLH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 241.71
Shares outstanding: 52846032
Market cap (USD): 12773414394.720001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLH — annual report dated 2024-12-31
Total revenue: 5889952000
Gross profit: 1824239000
Operating income: 670232000
Net income: 402299000
Capital expenditures: 423142000
Operating cash flow: 777771000
Depreciation & amortization: 400922000
Net tangible assets: 394343000
Owner earnings: 380079000
Return on net tangible assets (%): 96.38284437659601
Capex to operating income (%): 63.13366118000931
Buffett classification: The Good
Stock price: 230.14
P/E ratio: 30.23121062811491
Shares outstanding: 52846032
Book value: 2573529000
P/B ratio: 4.725800954440381
Market cap (USD): 12161985804.48
Debt to equity: 1.1815545890487342
Current ratio: 2.2071923864524705
Quick ratio: 1.8583496725209627
Effective tax rate (%): 24.58444482353316
Interest coverage ratio: 4.34085271468449
COGS to revenue (%): 69.0279479357387
SG&A to revenue (%): 12.557470756977306
Free cash flow (dilution-adjusted): 307942000
Buyback yield (%): 0.45369235655310985
Retained earnings: 2364877000
Inventory turnover: 10.569710157360973
Receivables turnover: 5.001776536806242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.681648522649688
FCF margin (%): 5.228259924698877
Revenue growth (%): 8.888639106462529
Rule of 40 score: 14.116899031161406
Financial ratios for CLH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 230.14
Shares outstanding: 52846032
Market cap (USD): 12161985804.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLH — quarterly report dated 2025-03-31
Total revenue: 1431950000
Gross profit: 410066000
Operating income: 111619000
Net income: 58680000
Capital expenditures: 117352000
Operating cash flow: 1605000
Depreciation & amortization: 111980000
Net tangible assets: 404960000
Owner earnings: 53308000
Return on net tangible assets (%): 13.163769261161596
Capex to operating income (%): 105.13622232773989
Buffett classification: The Gruesome
Stock price: 197.1
P/E ratio: 44.37607748466258
Shares outstanding: 52846032
Book value: 2571224000
P/B ratio: 4.050970630019011
Market cap (USD): 10415952907.199999
Debt to equity: 1.1804634679825639
Current ratio: 2.3666703197544305
Quick ratio: 1.981535177698821
Effective tax rate (%): 21.35102533172497
Interest coverage ratio: 2.676393717779643
COGS to revenue (%): 71.36310625370997
SG&A to revenue (%): 12.769091099549565
Free cash flow (dilution-adjusted): -124973000
Buyback yield (%): 0.528036181519037
Retained earnings: 2423557000
Inventory turnover: 2.717603131714997
Receivables turnover: 1.146845384306731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.78019484392773
FCF margin (%): -8.727469534550787
Rule of 40 score: -8.727469534550787
Financial ratios for CLH — quarterly report dated 2025-06-30
Total revenue: 1549854000
Gross profit: 516357000
Operating income: 210298000
Net income: 126905000
Capital expenditures: 87309000
Operating cash flow: 208040000
Depreciation & amortization: 116285000
Net tangible assets: 557082000
Owner earnings: 155881000
Return on net tangible assets (%): 27.98169748798202
Capex to operating income (%): 41.516799969566996
Buffett classification: The Good
Stock price: 231.18
P/E ratio: 65.8293810262683
Shares outstanding: 52846032
Book value: 2714067000
P/B ratio: 4.501342699999668
Market cap (USD): 12216945677.76
Debt to equity: 1.1174930464133714
Current ratio: 2.446633061527057
Quick ratio: 2.0677341240425005
Effective tax rate (%): 26.46982136752632
Interest coverage ratio: 4.98430982176716
COGS to revenue (%): 66.68350696259131
SG&A to revenue (%): 12.012937992869006
Free cash flow (dilution-adjusted): 111419000
Buyback yield (%): 0.09823240862768905
Retained earnings: 2550462000
Inventory turnover: 2.6959548820793477
Receivables turnover: 1.1962220520768372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2715019292399914
FCF margin (%): 7.188999738039842
Revenue growth (%): 8.233807046335418
Rule of 40 score: 15.42280678437526
Financial ratios for CLH — quarterly report dated 2025-09-30
Total revenue: 1549337000
Gross profit: 500847000
Operating income: 193009000
Net income: 118799000
Capital expenditures: 83258000
Operating cash flow: 301987000
Depreciation & amortization: 114729000
Net tangible assets: 633044000
Owner earnings: 150270000
Return on net tangible assets (%): 23.737686479928723
Capex to operating income (%): 43.136848540741624
Buffett classification: The Good
Stock price: 232.22
P/E ratio: 40.31718339676199
Shares outstanding: 52846032
Book value: 2775840000
P/B ratio: 4.4209700670932035
Market cap (USD): 12271905551.039999
Debt to equity: 1.089656104098219
Current ratio: 2.4435372658354972
Quick ratio: 2.090058009465886
Effective tax rate (%): 26.131968711526742
Interest coverage ratio: 4.57399815152736
COGS to revenue (%): 67.673462907037
SG&A to revenue (%): 12.238137990637284
Free cash flow (dilution-adjusted): 197869000
Buyback yield (%): 0.40743468723781595
Retained earnings: 2669261000
Inventory turnover: 2.778870312847859
Receivables turnover: 1.203963278170809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.98180703602581
FCF margin (%): 12.771204715307258
Revenue growth (%): -0.03335798081625753
Rule of 40 score: 12.737846734491
Financial ratios for CLH — annual report dated 2025-12-31
Total revenue: 6030837000
Gross profit: 1886238000
Operating income: 673372000
Net income: 390974000
Capital expenditures: 403350000
Operating cash flow: 866725000
Depreciation & amortization: 446006000
Net tangible assets: 613583000
Owner earnings: 433630000
Return on net tangible assets (%): 70.67177545662119
Capex to operating income (%): 59.90002554308762
Buffett classification: The Good
Stock price: 234.48
P/E ratio: 31.693507965644773
Shares outstanding: 52846032
Book value: 2745660000
P/B ratio: 4.513063373964729
Market cap (USD): 12391337583.359999
Debt to equity: 1.1056347107799218
Current ratio: 2.328583353784634
Quick ratio: 2.001285133355676
Effective tax rate (%): 25.94726564349666
Interest coverage ratio: 3.987918485309707
COGS to revenue (%): 68.72344585005365
SG&A to revenue (%): 12.478102127449308
Free cash flow (dilution-adjusted): 405457000
Buyback yield (%): 2.017554588583892
Retained earnings: 2755851000
Inventory turnover: 11.138760185762507
Receivables turnover: 5.0047401506192815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.379995464921818
FCF margin (%): 6.723063481901434
Revenue growth (%): 2.391954976882664
Rule of 40 score: 9.115018458784098
Financial ratios for CLH — quarterly report dated 2025-12-31
Total revenue: 1499696000
Gross profit: 458968000
Operating income: 158446000
Net income: 86590000
Capital expenditures: 115431000
Operating cash flow: 355093000
Depreciation & amortization: 103012000
Net tangible assets: 613583000
Owner earnings: 74171000
Return on net tangible assets (%): 12.088177149627679
Capex to operating income (%): 72.8519495601025
Buffett classification: The Good
Stock price: 234.48
P/E ratio: 31.693507965644773
Shares outstanding: 52846032
Book value: 2745660000
P/B ratio: 4.513063373964729
Market cap (USD): 12391337583.359999
Debt to equity: 1.1056347107799218
Current ratio: 2.328583353784634
Quick ratio: 2.001285133355676
Effective tax rate (%): 27.80677327374898
Interest coverage ratio: 3.7056457271153938
COGS to revenue (%): 69.39593090866416
SG&A to revenue (%): 12.928886921082672
Free cash flow (dilution-adjusted): 221142000
Buyback yield (%): 1.0733385246367877
Retained earnings: 2755851000
Inventory turnover: 2.7969942594225023
Receivables turnover: 1.244535175618763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4424371097031097
FCF margin (%): 14.745788479798572
Revenue growth (%): -3.20401565314712
Rule of 40 score: 11.541772826651451
Financial ratios for CNTX — annual report dated 2021-12-31
Capital expenditures: 250000
Buffett classification: The Gruesome
Stock price: 2.66
Shares outstanding: 91879177
Market cap (USD): 244398610.82000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -14881203
Net income: -14835939
Capital expenditures: 36836
Operating cash flow: -13549234
Depreciation & amortization: 9268
Net tangible assets: 34758366
Owner earnings: -14863507
Return on net tangible assets (%): -42.76238704661778
Buffett classification: The Gruesome
Stock price: 0.65
Shares outstanding: 91879177
Book value: 34758366
P/B ratio: 1.7181896597210582
Market cap (USD): 59721465.050000004
Debt to equity: 0.0015845969284056678
Current ratio: 11.801324800620531
Quick ratio: 11.801324800620531
Free cash flow (dilution-adjusted): -15062510
Buyback yield (%): 0
Retained earnings: -44090379
Capitalized R&D asset: 7091163
ROCI (R&D-adjusted, %): -24.262545463773318
Rule of 40 score: 0
Financial ratios for CNTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -25072616
Net income: -23964211
Capital expenditures: 0
Operating cash flow: -21047618
Depreciation & amortization: 12044
Net tangible assets: 11871020
Owner earnings: -23952167
Return on net tangible assets (%): -201.7700837838703
Buffett classification: The Gruesome
Stock price: 1.13
Shares outstanding: 91879177
Book value: 11871020
P/B ratio: 8.745960331125715
Market cap (USD): 103823470.00999999
Debt to equity: 0
Current ratio: 3.828316333529355
Quick ratio: 3.828316333529355
Free cash flow (dilution-adjusted): -22124483
Buyback yield (%): 0
Retained earnings: -68054590
Capitalized R&D asset: 22533810.21
ROCI (R&D-adjusted, %): -45.287777631500184
Rule of 40 score: 0
Financial ratios for CNTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 91879177
Market cap (USD): 180083186.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0